Jessup Christopher A. 4

4 · AAR CORP · Filed Jan 17, 2025

Form 4

Period: 2025-01-15

Senior Vice President-CCO

Transactions

Exercise/Conversion
Stock Option
2025-01-15−500→ 26,393 total
Exercise: $18.94From: 2021-07-31Exp: 2030-07-31→ Common Stock (500 underlying)
Exercise/Conversion
Stock Option
2025-01-16−26,393→ 0 total
Exercise: $18.94From: 2021-07-31Exp: 2030-07-31→ Common Stock (26,393 underlying)
Exercise/Conversion
Common Stock
2025-01-15$18.94/sh+500$9,470→ 70,796.525 total
Sale
Common Stock
2025-01-15$70.19/sh−500$35,093→ 70,296.525 total
Exercise/Conversion
Common Stock
2025-01-16$18.94/sh+26,393$499,883→ 96,689.525 total
Sale
Common Stock
2025-01-16$70.35/sh−7,088$498,619→ 63,208.525 total
Sale
Common Stock
2025-01-16$70.42/sh−26,393$1,858,489→ 70,296.525 total

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.0000 to $70.7600 inclusive. The reporting person undertakes to provide AAR CORP., any security holder of AAR CORP., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.0000 to $70.6800 inclusive. The reporting person undertakes to provide AAR CORP., any security holder of AAR CORP., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The awarded stock option vested and became exercisable in 1/3 annual installments beginning on July 31, 2021 and vested as follows: 33 and 1/3% on each of July 31, 2021, July 31, 2022 and July 31, 2023.

Documents

2 files